Citation

Rado JT. Psychopharm Review 2009; 44(5): 33-40.

Copyright

(Copyright © 2009)

DOI

10.1097/01.idt.0000348429.43231.c5

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; suicide; systematic review; insomnia; depression; major depression; arachidonic acid; docosahexaenoic acid; clinical trial; treatment outcome; mood disorder; cadaver; review; clinical research; antidepressant agent; smoking; amitriptyline; citalopram; fluoxetine; fluvoxamine; mirtazapine; moclobemide; paroxetine; pathophysiology; unclassified drug; psychotropic agent; gastrointestinal symptom; neurotransmission; nonhuman; drug safety; placebo; drug blood level; hospital patient; trazodone; drug efficacy; meta analysis; puerperal depression; diarrhea; drug tolerability; drug megadose; thin layer chromatography; cohort analysis; low drug dose; omega 3 fatty acid; monotherapy; diagnostic and statistical manual of mental disorders; dizziness; mood stabilizer; treatment response; dietary intake; icosapentaenoic acid; frontal cortex; adjuvant therapy; brain derived neurotrophic factor; diet supplementation; taste disorder; fish; omega 6 fatty acid; lipid peroxidation; fish oil; icosapentaenoic acid ethyl ester; belching; cholesterol derivative; fatty acid derivative; food frequency questionnaire; omega 3 cholesteryl ester; omega 6 cholesteryl ester; omega polyunsaturated fatty acid